← Back to headlines
Truist Lowers Price Target for Alnylam Pharmaceuticals (ALNY)
Truist has adjusted its price target for Alnylam Pharmaceuticals (ALNY), lowering it from $515 to $505.
20 Apr, 21:31 — 20 Apr, 21:31
Sources
Showing 1 of 1 sources
Related Stories
Critical Heat Measurements in Vienna Senior Apartments Prompt Calls for Subsidized Air Conditioning
23m ago
New Study Reveals High CTE Prevalence in Deceased NFL Players
35m ago
Latvian Government Increases Funding for Home Hospice Care
35m ago
Europe Records Over 35,000 Excess Deaths Due to Heatwaves
1h ago